Haixiao Chen

Haixiao Chen serves as the Senior Vice President and Head of Global Drug Safety & Pharmacovigilance at Xenon Pharmaceuticals Inc. since August 2023, leading drug safety initiatives for neurological and psychiatric disorders across clinical developments. Prior to this, Haixiao held various senior leadership positions in pharmacovigilance and risk management at Vir Biotechnology, Endo Pharmaceuticals, and Bristol Myers Squibb, overseeing significant safety programs and ensuring regulatory compliance. Extensive experience includes building and managing pharmacovigilance departments, directing safety evaluations in clinical trials, and leading safety management teams across multiple therapeutic areas. Haixiao holds an MD from Zhejiang University and multiple advanced degrees, including an MBA and MPH in Biostatistics & Epidemiology.